The Effect of Vitamin C for Iron Supplementation During Pregnancy With Risk of Anemia
Vitamin C Anemia, Pregnancy Anemia

About this trial
This is an interventional prevention trial for Vitamin C Anemia focused on measuring Vitamin C, Pregnancy with anemia
Eligibility Criteria
Inclusion Criteria: Pregnant woman Antenatal care at Rajavithi Hospital Singleton pregnancy Provide inform consent with both patient and her husband Gestational age between 14-28 weeks Risk of anemia during pregnancy, including more than 2 pregnancies, teenage pregnancy, advanced maternal age over 35 years old, mothers with body mass index below 18. 5. Pregnant women with hemoglobin greater than 10.5 g/dL, hematocrit greater than 32 % in the first antenatal blood results. 6. Giving birth at Rajavithi Hospital 7. Can communicate and understand Thai language very well Exclusion Criteria: Receive vitamin C supplements during the program HIV infection Iron deficiency anemia or blood diseases such as thalassemia Gastrointestinal bleeding Antenatal hemorrhage Allergic to vitamin C or iron Congenital diseases including kidney disease, liver disease, joint disease and bleeding disorders. Symptoms that indicate infection, such as fever, sore throat, sputum, diarrhea, loose stools, etc. History of iron intake within the past 3 months Received blood components within the past 3 months or while participating in a research project Giving birth during the drug trial
Sites / Locations
- RajavithiRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Iron supplement with Vitamin C
Iron supplementation alone
Vitamin C with Iron supplement Drug: Vitamin C 500mg Triferdine(Component: Iodine 0.15 mg, Iron 60.81 mg, Folic acid 0.4 mg)
Iron supplement alone Drug: Triferdine Component: Iodine 0.15 mg, Iron 60.81 mg, Folic acid 0.4 mg